Search

Your search keyword '"Experimental glomerulonephritis"' showing total 178 results

Search Constraints

Start Over You searched for: Descriptor "Experimental glomerulonephritis" Remove constraint Descriptor: "Experimental glomerulonephritis"
178 results on '"Experimental glomerulonephritis"'

Search Results

1. GOLD NANOPARTICLES CHANGE REGULATED CELL DEATH OF ENTEROCYTES UNDER CONDITIONS OF EXPERIMENTAL GLOMERULONEPHRITIS.

2. PURIFIED IGG F C-BINDING PROTEINS FROM M22 GROUP A STREPTOCOCCUS ARE ABLE TO INDUCE EXPERIMENTAL GLOMERULONEPHRITIS

3. CAPACITY OF GROUP A (TYPE M12) STREPTOCOCCI TO BIND IMMUNE COMPLEXES AND THEIR ROLE IN PATHOGENESIS OF POST-STREPTOCOCCAL GLOMERULONEPHRITIS

4. THE DINAMICS OF SOME HORMONE'S CONCENTRATION AND SOME PROTEIN'S METABOLISM INDEXES IN THE RAT'S TISSUES DURING EXPERIMENTAL GLOMERULONEPHRITIS

5. ДИНАМИКА КОНЦЕНТРАЦИИ НЕКОТОРЫХ ГОРМОНОВ И ПОКАЗАТЕЛЕЙ БЕЛКОВОГО ОБМЕНА В ТКАНЯХ КРЫС ПРИ ЭКСПЕРИМЕНТАЛЬНОМ ГЛОМЕРУЛОНЕФРИТЕ

7. Ozonoterapia en la glomerulonefritis tóxica experimental por adriamicina Ozone therapy in the experimental toxic glomerulonephritis due to adriamicine

8. Researchers from Radboud University Medical Center Describe Findings in Experimental Glomerulonephritis (Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis).

9. SMAD3-dependent and -independent pathways in glomerular injury associated with experimental glomerulonephritis

10. Endogenous IL-22 is dispensable for experimental glomerulonephritis

11. Endothelial-Specific Deletion of CD146 Protects Against Experimental Glomerulonephritis in Mice

12. New Research on Diabetic Nephropathy from Radboud University Medical Center Summarized (Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy).

13. Mechanism of Chronic Kidney Disease Progression and Novel Biomarkers: A Metabolomic Analysis of Experimental Glomerulonephritis

15. Вплив уведення наночастинок срібла на ооцити й клітини їх фолікулярного оточення в умовах експериментального гломерулонефриту

16. BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases

17. Coagulation in the mesangial area promotes ECM accumulation through factor V expression in MsPGN in rats.

18. Isotretinoin alleviates renal damage in rat chronic glomerulonephritis.

19. Localization of annexin V in rat normal kidney and experimental glomerulonephritis.

20. 211. A NOVEL P2X7 KNOCKOUT RAT IS NOT PROTECTED FROM EXPERIMENTAL GLOMERULONEPHRITIS OR VASCULITIS

21. Streptococcal IgG Fc-binding proteins are factors initiating experimental glomerulonephritis.

23. Experimental acute glomerulonephritis induced in the rabbit with a specific streptococcal antigen.

24. Production of interleukin 1 in glomerular cell cultures from rats with nephrotoxic serum nephritis.

25. Experimental glomerulonephritis induced by human IgG in rats.

26. Characterization of the mononuclear cell infiltrate in the glomerulus of rats with glomerulonephritis.

27. Signaling role of PDE isozymes in pathobiology of glomerular mesangial cells.

28. A scanning electron microscopic study of crescentic Masugi nephritis in the rabbit.

29. The temporal relationship between glomerular cell proliferation and monocyte infiltration in Experimental glomerulonephritis.

30. Rat malarial glomerulonephritis.

31. Experimental immune complex glomerulonephritis: Immunofluorescent, light and electron microscopic study.

32. Resumption of Meiotic Maturation of Oocytes, Pre- and Post-Implantational Embryonic Mortality under Conditions of Experimental Glomerulonephritis and Treatment of Silver Nanoparticles

33. Neutrophil exocytosis induces podocyte cytoskeletal reorganization and proteinuria in experimental glomerulonephritis

34. Role of jnk signalling in podocyte damage and proteinuria in experimental glomerlular disease.

35. The c3ar promotes macrophage infiltration and regulates anca production but does not affect glomerular injury in experimental antimyeloperoxidase glomerulonephritis.

39. Interleukin-17RA Promotes Humoral Responses and Glomerular Injury in Experimental Rapidly Progressive Glomerulonephritis.

40. Induced regulatory T cells are phenotypically unstable and do not protect mice from rapidly progressive glomerulonephritis.

41. ISN Forefronts Symposium 2010 in Sylt, Germany: ‘Induction and Resolution of Renal Inflammation’

43. FP084PODOCYTE-EXPRESSED STAT5 CONFERS PROTECTION DURING EXPERIMENTAL GLOMERULONEPHRITIS AND ADRIAMYCIN NEPHROPATHY IN MICE

44. FP168GROUP 1 INNATE LYMPHOID CELL INVOLVEMENT IN THE PROGRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS IS INHIBITED BY PPAR-ALPHA

45. Protective Role of BCG in the Rabbit Model of Mesangial Proliferative Glomerulonephritis.

48. Application of Antisense Oligodeoxynucleotides (ODNs) for the Intervention of Kidney Disease

49. Inhibition of experimental poststreptococcal glomerulonephritis in rabbits by IgG Fc fragments

50. Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor β

Catalog

Books, media, physical & digital resources